Page 23 - Noble-Virtual-Healthcare-2024

DarioHealth Corp.

SELECTED FINANCIAL ITEMS DRIO

(in millions of USD)
CQ1 '23 CQ2 '23 CQ3 '23 CQ4 '23 LTM
Income Statement Key Items
Total Revenue 7.07 6.15 3.52 3.62 20.35
Gross Profit 4.25 3.17 1.72 1.24 10.37
Gross Margin 60% 51% 49% 34% 51%
EBIT (12.41) (14.02) (15.55) (14.09) (56.06)
EBIT Margin -176% -228% -442% -390% -275%
Net Income to Common Shareholders (12.83) (16.59) (15.73) (14.29) (59.43)
Net Margin -182% -270% -447% -395% -292%

Balance Sheet Key Items
Total Assets 108.01 117.16 106.51 96.39 96.39
Cash & Short Term Investments 38.79 52.60 43.88 36.80 36.80
% of Assets 36% 45% 41% 38% 38%
Current Assets -Total 55.48 65.78 56.21 47.33 47.33
% of Assets 51% 56% 53% 49% 49%
Total Liabilities 35.98 38.76 38.47 38.25 38.25
% of Assets 33% 33% 36% 40% 40%
Current Liabilities - Total 17.62 8.08 8.11 12.49 12.49
% of Assets 16% 7% 8% 13% 13%
Long Term Debt 16.75 29.09 29.00 24.59 24.59
% of Assets 16% 25% 27% 26% 26%
Total Equity 72.03 78.40 68.04 58.14 58.14
% of Assets 67% 67% 64% 60% 60%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (4.76) (9.64) (8.65) (7.34) (30.38)
Net Cash Flow - Investing (4.36) 4.18 (0.28) (0.08) (0.55)
Net Cash Flow - Financing (1.39) 19.44 0.20 0.00 18.25

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference